Dr Joanna Achinger-Kawecka

Research Officer

Research Officer

Conjoint/Adjunct Role(s)

Conjoint Associate Lecturer, St Vincent's Clinical School, Faculty of Medicine, UNSW Australia

Joanna completed her PhD on the identification of microRNAs for the prediction of breast cancer treatment outcome at the Dr. Margarete-Fischer-Bosch-Institute of Clinical Pharmacology (IKP) in Stuttgart, Germany in late 2013 and then moved to Australia to join the Cancer Epigenetics Research group at the Garvan Institute.

Research Interests

Epigenetic deregulation in cancer
Three-dimensional genome in normal and cancer biology

Awards and Honours

2011-2013 – FP7 Marie Curie Initial Training Network “Fighting Drug Failure” Fellow (Germany)

Education

2014 – PhD (Pharmaceutical Sciences), Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology and University Tuebingen - Germany
2011 – MSc (Biotechnology), Warsaw University of Life Sciences - Poland

Selected Publications

Reiner Hoppe*, Joanna Achinger-Kawecka*, Stefan Winter, Peter Fritz, Wing-Yee Lo, Werner Schroth, Hiltrud Brauch. Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment. European Journal of Cancer, 2013, doi:10.1016/j.ejca.2013.07.145 *Equal first authors

Taberlay PC*, Achinger-Kawecka J*, Lun AT, Buske FA, Sabir K, Gould CM, Zotenko E, Bert SA, Giles KA, Bauer DC, Smyth GK, Stirzaker C, O'Donoghue SI, Clark S. Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations. Genome Research 2016, Epub ahead of print *Equal first authors

Dr Joanna Achinger-Kawecka



Division Overview

Division Core Strengths Diagram